Effect of anti-sclerostin antibody on tooth movement in rats
Author Information
Author(s): Hyunna Ahn, Wonse Park, Sung-Hwan Choi, Namki Hong, Jisun Huh, Seoyeon Jung
Primary Institution: Yonsei University College of Dentistry, Seoul, Korea
Hypothesis
Anti-sclerostin antibodies would initially increase orthodontic tooth movement and subsequently decrease it.
Conclusion
Romosozumab initially accelerated tooth movements, but later decreased tooth movement as new alveolar bone was formed.
Supporting Evidence
- The ROMO group showed more tooth movement on day 7 of orthodontic treatment.
- On days 10 and 14, relatively less movement was observed in the ROMO group.
- Analysis revealed significant differences in the OPG/RANKL ratio between the two groups.
Takeaway
This study looked at how a special medicine affects tooth movement in rats. At first, the medicine helped the teeth move faster, but then it slowed them down.
Methodology
Twenty-four ovariectomized female rats were divided into two groups, one receiving romosozumab and the other a control, with orthodontic forces applied to measure tooth movement.
Limitations
The study did not include a comparison with normal rats or male cohorts.
Participant Demographics
Female Sprague-Dawley rats, 12 weeks old.
Statistical Information
P-Value
p=0.009
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website